PLK4 mRNA and protein are overexpressed in central nervous system neuroblastoma; downregulation of PLK4 promotes apoptosis, suppresses cell migration, invasion and metastases and inhibits EMT; can modulate sensitivity to cisplatin; high PLK4 expression correlates adversely with clinical features and worse OS and PFS. This evidence concerns the gene PLK4 and cerebral neuroblastoma.